Pfizer Ltd Analyst Rating
based on 3 analysts
66.67%
Buy
33.33%
Hold
0.00%
Sell
Based on 3 analysts offering long term price targets for Pfizer Ltd. An average target of ₹5935
Source: S&P Global Market Intelligence
Pfizer Ltd Share analysis
Pfizer Ltd price forecast by 3 analysts
Upside of18.41%
High
₹7175
Target
₹5935.00
Low
₹5300
Pfizer Ltd target price ₹5935, a slight upside of 18.41% compared to current price of ₹4669.95. According to 3 analysts rating.
Excluding Excise Duty and Other Income, represents Net Revenue
Pfizer Ltd revenue growth forecast
Expected growth rate Q1, FY2026:0
Forecast
Actual
Including amortisation and stock based compensations
Pfizer Ltd EPS growth forecast
EPS estimate Q1, FY2026:0
Forecast
Actual
Source: S&P Global Market Intelligence
Pfizer Ltd Performance
Day's Low
Day's High
₹4,601Day's Price Range₹5,055.552 Week's Low
52 Week's High
₹3,95052-Week Price Range₹6,451.15
| Returns % | |
| 1 Month Return | -2.32 % |
| 3 Month Return | -9.66 % |
| 1 Year Return | + 18.76 % |
| Market Stats | |
| Previous Close | ₹5,012.40 |
| Open | ₹5,012.40 |
| Volume | 3.37L |
| Upper Circuit | - |
| Lower Circuit | - |
| Market Cap | ₹23,100.09Cr |
Pfizer Ltd Key Statistics
| P/E Ratio | 0 |
| PEG Ratio | 0 |
| Market Cap | ₹23,100.09 Cr |
| P/B Ratio | 5.34 |
| EPS | 98.27 |
| Dividend Yield | 0 |
| Sector | Pharmaceuticals |
| ROE | 16.21 |
Pfizer Ltd Peer Comparison
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
|---|---|---|---|---|---|---|
| BUY | ₹23,100.09 Cr | 3.59% | 0.52 | NA | NA | |
| BUY | ₹14,100.35 Cr | -2.24% | 0.52 | ₹602 Cr | ₹2,851 Cr | |
| BUY | ₹73,098.77 Cr | 33.6% | 0.56 | ₹3,168 Cr | ₹29,001 Cr | |
| HOLD | ₹98,565.65 Cr | 55.28% | 0.64 | ₹3,854 Cr | ₹19,547 Cr | |
| BUY | ₹59,732.90 Cr | 24.06% | 0.53 | NA | NA |
Pfizer Ltd Mutual Fund Holdings
About Pfizer Ltd
Share Price: ₹4669.95 per share as on 20 Dec, 2024 04:01 PM
Market Capitalisation: ₹23,100.09Cr as of today
Listing date: 09 Dec, 1994
Chairperson Name: Pradip P Shah
| Organisation | Pfizer Ltd |
| Headquarters | |
| Industry | Pharmaceuticals |
| E-voting on shares | Click here to vote |
Key events for Pfizer Ltd
Pfizer Expands Manufacturing and R&D in India - 12 Nov, 2024
Pfizer Limited is enhancing its manufacturing and R&D capabilities in India, shifting oncology products to Gujarat, and aiming to introduce more made-in-India products and adult vaccinations.Pfizer Reports Positive Q2 Earnings Growth - 28 Oct, 2024
Pfizer Ltd announced a 6.3% increase in net profit to ₹158 crore for Q2 2024, with revenue up 2.3% to ₹589 crore. EBITDA also showed growth, reflecting improved margins.
Insights on Pfizer Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTMF Holding Up
Mutual Funds have increased holdings from 8.32% to 10.43% in Sep 2024 quarter
- POSITIVE IMPACT
FII Holding Up
Foreign Institutions have increased holdings from 3.22% to 3.54% in Sep 2024 quarter
- POSITIVE IMPACT
Price Rise
In the last 3 years, PFIZER stock has moved up by 4.8%
NO EFFECTAgainst Peers
In the last 1 year, Divis Laboratories Ltd has given 57.1% return, outperforming this stock by 38.0%
- NO EFFECT
Promoter Holding Unchanged
Promoters holdings remained unchanged at 63.92% of holdings in Sep 2024 quarter
- NO EFFECT
Against Peers
In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 135.8% return, outperforming this stock by 130.9%
NEGATIVE IMPACTRetail Holding Down
Retail Investor have decreased holdings from 17.01% to 16.50% in Sep 2024 quarter
Pfizer Ltd Financials
Index Inclusions
Pfizer Ltd Shareholding Pattern
| Investors | Holdings % | FY Quarter | 3M change |
|---|---|---|---|
| Promoter Holdings | 63.92% | 0.00 | |
| Foreign Institutions | 3.54% | 9.89 | |
| Mutual Funds | 10.43% | 25.33 | |
| Retail Investors | 16.5% | ||
| Others | 5.61% |
Pfizer Ltd Key Indicators
Pfizer Ltd Earnings and Dividends
Pfizer Ltd Earnings Results
Pfizer Ltd’s net profit jumped 6.3% since last year same period to ₹158.35Cr in the Q2 2024-2025. On a quarterly growth basis, Pfizer Ltd has generated 5.07% jump in its net profits since last 3-months.
Read More about Earnings ResultsPfizer Ltd Dividends May,2024
In the quarter ending March 2024, Pfizer Ltd has declared dividend of ₹35 - translating a dividend yield of 0.75%.
Read More about Dividends
Pfizer Ltd Technicals Summary
Bearish
Neutral
Bullish
Pfizer Ltd is currently in a Bearish trading position according to technical analysis indicators.
FAQs on Pfizer Ltd
- Get a PAN card.
- Open a Demat account.
- Open a Trading account.
- Link your Demat account to your Trading account.
- Fund your Trading account.
- Place an order to buy Pfizer Ltd shares.
Pfizer Ltd (PFIZER) share price today is ₹4669.95
Pfizer Ltd is listed on NSE
Pfizer Ltd is listed on BSE
- Today’s highest price of Pfizer Ltd is ₹5055.5.
- Today’s lowest price of Pfizer Ltd is ₹4601.
Today’s traded volume of Pfizer Ltd(PFIZER) is 3.37L.
Today’s market capitalisation of Pfizer Ltd(PFIZER) is ₹23100.09Cr.
| Pfizer Ltd(PFIZER | Price |
|---|---|
52 Week High | ₹6451.15 |
52 Week Low | ₹3950 |
Pfizer Ltd(PFIZER) share price is ₹4669.95. It is down -27.61% from its 52 Week High price of ₹6451.15
Pfizer Ltd(PFIZER) share price is ₹4669.95. It is up 18.23% from its 52 Week Low price of ₹3950
| Pfizer Ltd(PFIZER | Returns |
|---|---|
1 Day Returns | -342.45% |
1 Month Returns | -2.32% |
3 Month Returns | -9.66% |
1 Year Returns | 18.76% |